Inhibition of Tumor Growth through Macrophage Activation by Polysaccharide Fraction from Peonia japonica (PJ-P)

백작약 조다당분획에 의한 대식세포 활성화를 통한 암세포 증식 억제

  • 박혜란 (한국원자력연구소 방사선식품생명공학기술개발팀) ;
  • 정우희 (한국원자력연구소 방사선식품생명공학기술개발팀) ;
  • 정일윤 (한국원자력연구소 방사선식품생명공학기술개발팀) ;
  • 이성태 (순천대학교 생물학과) ;
  • 조성기 (한국원자력연구소 방사선식품생명공학기술개발팀)
  • Published : 2003.02.01


The immunomodulatory activity of PJ-P, a polysaccharide fraction extracted from Paeonia japonica, were reported in our previous paper. In the present study, we investigated that PJ-P inhibited cancer growth through activation of macrophages. The activities of peritoneal macrophage to induce tumor necrosis factor (TNF)-$\alpha$, interleukin-1 (IL-1)$\beta$, interleukin-6 (IL-6) and interleukin-12 (IL-12) as well as to ingest fluorescence-latex microbeads were enhanced by treatment of PJ-P. Direct cytocidal activity of PJ-P against cancer cells was not shown. However, in vitro, peritoneal macrophages treated with PJ-P had an activity to kill cancer cells. Furthermore, PJ-P significantly prolonged the survival of mice implanted intraperitoneally with B16F0 mel-anoma cells. These results suggest that PJ-P could be a useful immunomodulator and assistant of anti-tumor agent.


  1. Aimi N, Inaba M, Watanabe M, Shibata S. 1969. Chemical studies on the oriental plant drugs. XXIII. Paeoniflorin, a glucoside of Chinese paeony root. Tetrahedron 25: 1825- 1838.
  2. Egger K, Keil M. 1969. Flavone glycosides in the flowers of Paeonia arborea and P. suffruicosa. Planta 88: 154-156.
  3. 김도순. 1990. 시호.백작약의 항스트레스효과에 관한 실험적 연구. 석사학위논문, 원광대학교.
  4. 정동주. 1986. 백작약수침이 생쥐의 진통 및 항경련효과에 미치는 영향. 석사학위논문, 대구한의과대학.
  5. Park HR, Ham YH, Yee ST, Paik SG, Jo SK. 2001. Characteristics of B cell proliferation by polysaccharide fraction of Paeonia japonica miyabe. Official J Korean Assoc Immunobiol 1: 126-134.
  6. Cavaillon JM. 1994. Cytokines and macrophages. Biomed Pharmacother 48: 445-453.
  7. Arden L, Lansdorp P, De Groot E. 1985. A growth factor for B cell hybridomas produced by human monocytes. Lymphokines 10: 175-185.
  8. Arenzana-Seisdedos F, Virelizier J. 1983. Interferons as macrophage activating factors. II. Enhanced secretion of interleukin 1 by lipopolysaccaride- stimulated human monocytes. Eur J Immunol 13: 437-440.
  9. Choriki M, Freudenberg M, Calanos C, Pondron P, Bartholeyns J. 1989. Antitumoral effects of lipopolysaccharide, tumor necrosis factor, interferon and activated macrophages: synergism and tissue distribution. Anticancer Res 9: 1185- 1190.
  10. Stuehr DJ, Marletta MA. 1987. Synthesis of nitrite and nitrate in macrophage cell lines. Cancer Res 47: 5590-5594.
  11. Yin ET, Galanos C, Kinsky S. 1972. Picogram-sensitivity assay for endotoxin; Gelatination of Limulus polyphemus blood cell lysate induced by purified lipopolysaccharide and lipid A from gram-negative bacteria. Biochem Biophys Acta 261: 284-289.
  12. Iwao S, Hideki T, Yoshiyuki A, Toshiro Y. 1988. Rapid measurement of phagocytosis by macrophages. Chem Pharm Bull 36: 4871-4875.
  13. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum JS. 1982. Analysis of nitrate, nitrite, and [$^{15}N$] nitrate in biological fluids. Anal Biochem 126: 131-138.
  14. Yoshinori U, Uutaka K, Sumio S, Yoshinori I, Minoru T, Yasuo H, Yoshiro N. 1994. Immunochemotherapy in B-16- melanoma-cell-transplanted mice with combinations of interleukin-2, cyclophosphamide, and PSK. Oncology 51: 296-302.
  15. Han SB, Lee CW, Heon YJ, Hong ND, Yoo ID, Yang KH, Kim HM. 1999. The inhibitory effect of polysaccharides isolated from Phellinus linteus on tumor growth and metastasis. Immunopharmacol 41: 157-164.
  16. Ding A, Nathan CF, Steuhr DJ. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from peritoneal macrophages: Comparison of activating cytokines and evidence for independent production. J Immunol 141: 2407-2412.
  17. Segan AW. 1989. The electron transport chain of the microbicidal oxidase of phagocytic cells and its involvement in the molecular pathology of chronic granulomatous disease. J Clin Invest 83: 1785-1793.
  18. Farias-Eisner R, Sherman MP, Aerberhard E, Chaudhuri G. 1994. Nitric oxide is an important mediator of tumoricidal activity in vivo. Proc Natl Acad Sci 91: 9407-9411.
  19. Adams DO, Hamilton TA. 1884. The cell biology of macrophage activation. Annual Review Immunology 2: 283-318.
  20. Balkwill FR, Maylor MS, Malik S. 1990. Tumor necrosis actor as an anticancer agent. Eur J Immunol 26: 641-644.
  21. Hamilton TA, Adams DO. 1987. Molecular mechanisms of signal transduction in macrophage activation. Immunol Today 8: 151-158.
  22. Mateo RB, Reichner JS, Albina JE. 1996. NO is not sufficient to explain maximal cytotoxicity of tumoricidal macrophages against an NO-sensitive cell line. J Leukoc Biol 60: 245-52.
  23. Hibbs JB, Taintor R, Vavrin Z, Rachlin C. 1988. Nirtic oxide; A ctotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 157: 87-94.

Cited by

  1. Effects of Paeoniae radix alba(PRA) on Skin whitening and Elasticity using Melanoma cells vol.25, pp.1, 2012,